SCHEMBL5732656

SCHEMBL5732656

FC(F)(F)c1cccc(Nc2nccc(-c3ccccn3)n2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 5/20 0.66
▸ ABL1 P00519 1/20 0.60
▸ BCR P11274 1/20 0.60
▸ PRKCA P17252 1/20 0.60
▸ CLK1 P49759 1/20 0.59
▸ CLK2 P49760 1/20 0.59
▸ DYRK1A Q13627 1/20 0.59
▸ CLK4 Q9HAZ1 1/20 0.59
▸ DYRK1B Q9Y463 1/20 0.59
▸ IDH2 P48735 1/20 0.58
▸ SYK P43405 5/20 0.55
▸ MTOR P42345 1/20 0.55
▸ SMG1 Q96Q15 1/20 0.55
▸ GSK3B P49841 2/20 0.55
▸ CDK2 P24941 2/20 0.55
▸ CDK4 P11802 1/20 0.54
▸ KDM4E B2RXH2 1/20 0.54
▸ FLT1 P17948 1/20 0.54
▸ FLT4 P35916 1/20 0.54
▸ KDR P35968 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7469928 0.83 ABL1 (0.64) ABL1BCRPRKCACLK2DYRK1A
SCHEMBL4901590 0.82 ABL1 (0.67) AURKAABL1BCRPRKCACLK1
SCHEMBL6663767 0.82 AURKA (0.72) AURKAIDH2KDM4E
SCHEMBL31501743 0.82 AURKA (0.72) AURKAIDH2KDM4E
SCHEMBL25337941 0.81 AURKA (0.62) AURKACLK1CLK2DYRK1ACLK4
SCHEMBL30554562 0.81 AURKA (0.62) AURKACLK1CLK2DYRK1ACLK4
SCHEMBL27119202 0.81 AURKA (0.60) AURKACLK1CLK2DYRK1ACLK4
SCHEMBL7470857 0.80 ABL1 (0.63) AURKAABL1BCRPRKCASYK
SCHEMBL4903508 0.80 ABL1 (0.67) ABL1BCRPRKCASYKCDK2
SCHEMBL5734023 0.80 ABL1 (0.64) ABL1BCRPRKCASYKCDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0672042-B1 PHARMACOLOGICALLY ACTIVE PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 2006-05-03 — — EP disclosed
US-5705502-A Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof NOVARTIS CORPORATION (US) 1998-01-06 — — US disclosed
Send feedback